Adherence and HIV drug resistance (Reprinted from The Hopkins HIV Report)

被引：10

作者：

Sethi, AK

机构：

来源：

HIV CLINICAL TRIALS | 2004年 / 5卷 / 02期

关键词：

D O I：

10.1310/N53E-1930-NJMW-GL7C

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：112 / 115

页数：4

共 11 条

[1] High levels of adherence do not prevent accumulation of HIV drug resistance mutations [J].

Bangsberg, DR ;

Charlebois, ED ;

Grant, RM ;

Holodniy, M ;

Deeks, SG ;

Perry, S ;

Conroy, KN ;

Clark, R ;

Guzman, D ;

Zolopa, A ;

Moss, A .

AIDS, 2003, 17 (13) :1925-1932

[2] Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy [J].

Descamps, D ;

Flandre, P ;

Calvez, V ;

Peytavin, G ;

Meiffredy, V ;

Collin, G ;

Delaugerre, C ;

Robert-Delmas, S ;

Bazin, B ;

Aboulker, JP ;

Pialoux, G ;

Raffi, F ;

Brun-Vézinet, F .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (02) :205-211

[3] Drug resistance in patients experiencing early virological failure under a triple combination including indinavir [J].

Gallego, O ;

de Mendoza, C ;

Pérez-Elías, MJ ;

Guardiola, JM ;

Pedreira, J ;

Dalmau, D ;

Gónzalez, J ;

Moreno, A ;

Arribas, JR ;

Rubio, A ;

García-Arata, I ;

Leal, M ;

Domingo, P ;

Soriano, V .

AIDS, 2001, 15 (13) :1701-1706

[4] Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens [J].

Havlir, DV ;

Hellmann, NS ;

Petropoulos, CJ ;

Whitcomb, JM ;

Collier, AC ;

Hirsch, MS ;

Tebas, P ;

Sommadossi, JP ;

Richman, DD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (02) :229-234

[5] Antiretroviral drug resistance testing in adult HIV-1 infection -: Recommendations of an International AIDS Society-USA panel [J].

Hirsch, MS ;

Brun-Vézinet, F ;

D'Aquila, RT ;

Hammer, SM ;

Johnson, VA ;

Kuritzkes, DR ;

Loveday, C ;

Mellors, JW ;

Clotet, B ;

Conway, B ;

Demeter, LM ;

Vella, S ;

Jacobsen, DM ;

Richman, DD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18) :2417-2426

[6] Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission [J].

Jackson, JB ;

Becker-Pergola, G ;

Guay, LA ;

Musoke, P ;

Mracna, M ;

Fowler, MG ;

Mofenson, LM ;

Mirochnick, M ;

Mmiro, F ;

Eshleman, SH .

AIDS, 2000, 14 (11) :F111-F115

[7] A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients - The INCAS trial [J].

Montaner, JSG ;

Reiss, P ;

Cooper, D ;

Vella, S ;

Harris, M ;

Conway, B ;

Wainberg, MA ;

Smith, D ;

Robinson, P ;

Hall, D ;

Myers, M ;

Lange, JMA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (12) :930-937

[8] Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance [J].

Sethi, AK ;

Celentano, DD ;

Gange, SJ ;

Moore, RD ;

Gallant, JE .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (08) :1112-1118

[9] Patient compliance and drug failure in protease inhibitor monotherapy [J].

Vanhove, GF ;

Schapiro, JM ;

Winters, MA ;

Merigan, TC ;

Blaschke, TF .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (24) :1955-1956

[10]

WALSH, 2002, J ACQ IMMUN DEF SYND, V30, P279

← 1 2 →